# Laurence H. Beck

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/laurence-h-beck/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,705 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 48 |
| i10-index | 97 |
| Last Known Institution | Boston University |
| OpenAlex ID | https://openalex.org/A5004456379 |
| ORCID iD | 0000-0003-1482-4089 |
| Works | 199 |

## Researcher papers

- [M-Type Phospholipase A <sub>2</sub> Receptor as Target Antigen in Idiopathic Membranous Nephropathy](https://scholariq.org/papers/m-type-phospholipase-a-sub-2-sub-receptor-as-target-antigen-in-idiopathic/)
- [Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy](https://scholariq.org/papers/thrombospondin-type-1-domain-containing-7a-in-idiopathic-membranous-nephropathy/)
- [Vascular development: cellular and molecular regulation](https://scholariq.org/papers/vascular-development-cellular-and-molecular-regulation/)
- [Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy](https://scholariq.org/papers/rituximab-induced-depletion-of-anti-pla2r-autoantibodies-predicts-response-in/)
- [Membranous nephropathy](https://scholariq.org/papers/membranous-nephropathy/)
- [Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy](https://scholariq.org/papers/anti-phospholipase-a2-receptor-antibody-in-membranous-nephropathy/)
- [Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy](https://scholariq.org/papers/anti-phospholipase-a2-receptor-antibodies-correlate-with-clinical-status-in/)
- [Endothelial Cells Modulate the Proliferation of Mural Cell Precursors via Platelet-Derived Growth Factor-BB and Heterotypic Cell Contact](https://scholariq.org/papers/endothelial-cells-modulate-the-proliferation-of-mural-cell-precursors-via/)
- [KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis](https://scholariq.org/papers/kdoqi-us-commentary-on-the-2012-kdigo-clinical-practice-guideline-for/)
- [The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis](https://scholariq.org/papers/the-genetic-architecture-of-membranous-nephropathy-and-its-potential-to-improve/)
- [Primary membranous nephropathy: comprehensive review and historical perspective](https://scholariq.org/papers/primary-membranous-nephropathy-comprehensive-review-and-historical-perspective/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)

## Researcher university

- [Boston University](https://scholariq.org/institutions/boston-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.